Inhibitors of protein-protein interactions as potential drugs

被引:19
作者
Veselovsky, Alexander V. [1 ]
Archakov, Alexander I. [1 ]
机构
[1] Inst Biomed Chem, Moscow 119121, Russia
关键词
protein-protein interaction; inhibitors; target; dimerization; drug; flexibility; allosteric inhibition;
D O I
10.2174/157340907780058754
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein-protein interactions play a crucial role in numerous Vital cell functions. However protein-protein interactions are also responsible for pathological formation of protein aggregates, which determine the development of several diseases. The key role of protein-protein interactions for manifestation of numerous cell functions attracts much attention to protein complexes as perspective drug targets. So design or discovery of small molecules that would regulate protein-protein interactions represents great pharmacological interest. The recent progress in understanding of mechanism protein-protein interaction, including role of flexibility of protein-protein interfaces, thermodynamic of complex formation, discovery of small molecules modifying protein-protein interactions, the advantages and limitation of protein-protein inhibitors as potential drugs are discussed in this review.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 118 条
[1]  
Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569
[2]   Converting a peptide into a drug: Strategies to improve stability and bioavailability [J].
Adessi, C ;
Soto, C .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (09) :963-978
[3]   Similarity study on peptide gamma-turn conformation mimetics [J].
Alkorta, I ;
Suarez, ML ;
Herranz, R ;
GonzalezMuniz, R ;
GarciaLopez, MT .
JOURNAL OF MOLECULAR MODELING, 1996, 2 (01) :16-25
[4]   Peptidomimetics - Antagonists of the fibrinogen receptors: Molecular design, structures, properties and therapeutic applications [J].
Andronati, SA ;
Karaseva, TL ;
Krysko, AA .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (09) :1183-1211
[5]  
[Anonymous], PROTEIN PROTEIN RECO
[6]   Protein-protein interactions as a target for drugs in proteomics [J].
Archakov, AI ;
Govorun, VM ;
Dubanov, AV ;
Ivanov, YD ;
Veselovsky, AV ;
Lewi, P ;
Janssen, P .
PROTEOMICS, 2003, 3 (04) :380-391
[7]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[8]   Binding of small molecules to an adaptive protein-protein interface [J].
Arkin, MR ;
Randal, M ;
DeLano, WL ;
Hyde, J ;
Luong, TN ;
Oslob, JD ;
Raphael, DR ;
Taylor, L ;
Wang, J ;
McDowell, RS ;
Wells, JA ;
Braisted, AC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1603-1608
[9]   Inhibiting HIV-1 entry with fusion inhibitors [J].
Baldwin, CE ;
Sanders, RW ;
Berkhout, B .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) :1633-1642
[10]   Modulation of protein-protein interactions with small organic molecules [J].
Berg, T .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (22) :2462-2481